Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis

  • 14 Accesses

  • 51 Citations

Summary

To study the source and role of circulating phospholipase A2 (PLA2) catalytic activity we monitored the serum from patients with necrotizing pancreatitis (n=8), diffuse peritonitis (n=6), and multiple injuries (n=11). Immunoreactive PLA2 serum protein concentration was analysed using a fluoroimmunoassay based on an antibody against human pancreatic PLA2. Serum PLA2 catalytic activity was analysed using a radiochemical method based on a substrate with tritiated palmitic acid in beta position. In necrotizing pancreatitis immunoreactive PLA2 and PLA2 catalytic activity both increased. Obviously, in necrotizing pancreatitis the major part of serum catalytic activity stems from the pancreas. In patients with diffuse peritonitis and multiple injuries, as a rule, immunoreactive phospholipase A2 serum concentration appears to be within the normal range. In contrast, in these patients we demonstrated high serum catalytic PLA2 activity comparable to that in necrotizing pancreatitis. The source of catalytic PLA2 activity in peritonitis and multiple injuries seems not to be the pancreas. There was a correlation between pulmonary insufficiency and serum PLA2 catalytic activity in patients with necrotizing pancreatitis, peritonitis, and multiple injuries.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Baker SP, O'Neill B, Haddon W, Long WB (1974) The injury severity score. J Trauma 14:187–196

  2. 2.

    Beger HG, Krautzberger W, Bittner R (1983) Die Therapie der diffusen bakteriellen Peritonitis mit kontinuierlicher Peritoneallavage. Chirurg 54:311–315

  3. 3.

    Beger HG, Büchler M, Bittner R, Block S, Nevalainen T, Roscher R (1988) Necrosectomy and postoperative local lavage in necrotizing pancreatitis. Br J Surg 75:207–212

  4. 4.

    Block S, Maier W, Bittner R, Büchler M, Malfertheiner P, Beger HG (1986) Identification of pancreas necrosis in severe acute pancreatitis — imaging procedures versus clinical staging. Gut 27:1035–1042

  5. 5.

    Büchler M, Malfertheiner P, Schädlich H, Nevalainen T, Frieß H, Beger HG (1989) The role of phospholipase A2 in human acute pancreatitis (in press)

  6. 6.

    Eskola JU, Nevalainen TJ, Lövgren TNE (1983) Time resolved fluoroimmunoassay of human pancreatic phospholipase A2. Clin Chem 29:1777–1780

  7. 7.

    Nevalainen TJ (1988) Phospholipase A2 in acute pancreatitis. Scand J Gastroenterol (in press)

  8. 8.

    Schädlich HR, Büchler M, Beger HG (1987) Improved method for the determination of phospholipase A2 catalytic activity concentration in human serum and ascites. J Clin Chem Biochem 25:505–509

  9. 9.

    Schmid D, Hoffmann GE (1987) Phospholipase A in pancreatic and extrapancreatic diseases. Clin Chem 33:594–596

  10. 10.

    Vadas P, Pruzanski W (1986) Role of secretory phospholipase A2 in the pathobiology of disease. Lab Invest 55:391–404

  11. 11.

    Vadas P, Pruzanski W, Stefansky E, et al. (1988) Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse. Crit Care Med 16:1–7

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Büchler, M., Deller, A., Malfertheiner, P. et al. Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis. Klin Wochenschr 67, 217–221 (1989). https://doi.org/10.1007/BF01711357

Download citation

Key words

  • Immunoreactive phospholipase A2
  • Serum catalytic phospholipase A2 activity
  • Necrotizing pancreatitis
  • Diffuse peritonitis
  • Multiple injuries